Corbus Pharmaceuticals Holdings EBITDA Margin 2013-2020 | CRBP

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Corbus Pharmaceuticals Holdings (CRBP) over the last 10 years. The current EBITDA margin for Corbus Pharmaceuticals Holdings as of March 31, 2020 is .
Corbus Pharmaceuticals Holdings EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2020-03-31 $0.04B $-0.08B -216.22%
2019-12-31 $0.04B $-0.08B -205.41%
2019-09-30 $0.04B $-0.07B -183.33%
2019-06-30 $0.03B $-0.06B -164.71%
2019-03-31 $0.01B $-0.07B -1183.33%
2018-12-31 $0.01B $-0.06B -1120.00%
2018-09-30 $0.00B $-0.05B -1666.67%
2018-06-30 $0.00B $-0.04B -1400.00%
2018-03-31 $0.00B $-0.04B -1800.00%
2017-12-31 $0.00B $-0.03B -1600.00%
2017-09-30 $0.00B $-0.03B -1450.00%
2017-06-30 $0.00B $-0.03B -1350.00%
2017-03-31 $0.00B $-0.02B -1200.00%
2016-12-31 $0.00B $-0.02B -2000.00%
2016-09-30 $0.00B $-0.01B -1400.00%
2016-06-30 $0.00B $-0.01B inf%
2016-03-31 $0.00B $-0.01B inf%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.581B $0.036B
Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $61.956B 35.16
Takeda Pharmaceutical (TAK) Japan $61.163B 10.72
Astellas Pharma (ALPMY) Japan $30.429B 15.20
Eisai (ESALY) Japan $21.286B 39.65
UCB SA (UCBJF) Belgium $17.894B 0.00
Merck (MKGAF) Germany $14.831B 19.45
Grifols, S.A (GRFS) Spain $13.820B 17.18
Catalent (CTLT) United States $11.848B 45.80
Neurocrine Biosciences (NBIX) United States $11.041B 51.03
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Ionis Pharmaceuticals (IONS) United States $7.808B 41.51
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.391B 0.00
Orion OYJ (ORINY) Finland $6.879B 30.82
IPSEN SA ADR (IPSEY) France $6.586B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.049B 9.68
United Therapeutics (UTHR) United States $5.213B 9.88
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Nektar Therapeutics (NKTR) United States $4.056B 0.00
Evotec AG (EVTCY) Germany $3.888B 62.70
ChemoCentryx (CCXI) United States $3.662B 0.00
Hypermarcas (HYPMY) Brazil $3.529B 10.73
Arrowhead Pharmaceuticals (ARWR) United States $3.431B 374.56
FibroGen (FGEN) United States $3.235B 0.00
PTC Therapeutics (PTCT) United States $3.163B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.660B 10.93
Sage Therapeutics (SAGE) United States $2.028B 0.00
Pacira BioSciences (PCRX) United States $1.876B 38.40
Ironwood Pharmaceuticals (IRWD) United States $1.865B 14.27
Xencor (XNCR) United States $1.831B 0.00
Corcept Therapeutics (CORT) United States $1.788B 17.73
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.786B 0.00
USANA Health Sciences (USNA) United States $1.757B 18.02
Theravance Biopharma (TBPH) Cayman Islands $1.684B 0.00
Zogenix (ZGNX) United States $1.678B 0.00
Heron Therapeutics (HRTX) United States $1.671B 0.00
Indivior (INVVY) United States $1.641B 20.36
Akebia Therapeutics (AKBA) United States $1.583B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.488B 16.03
Karyopharm Therapeutics (KPTI) United States $1.411B 0.00
Portola Pharmaceuticals (PTLA) United States $1.399B 0.00
Tilray (TLRY) Canada $1.348B 0.00
Translate Bio (TBIO) United States $1.322B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.224B 0.00
Esperion Therapeutics (ESPR) United States $1.136B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.099B 49.04
Endo (ENDP) Ireland $0.880B 1.36
ImmunoGen (IMGN) United States $0.850B 0.00
Collegium Pharmaceutical (COLL) United States $0.804B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.802B 0.00
Molecular Templates (MTEM) United States $0.738B 0.00
Aerie Pharmaceuticals (AERI) United States $0.701B 0.00
Ardelyx (ARDX) United States $0.682B 0.00
Harpoon Therapeutics (HARP) United States $0.618B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.579B 0.00
Radius Health (RDUS) United States $0.568B 0.00
Innate Pharma SA (IPHYF) France $0.555B 0.00
Trillium Therapeutics (TRIL) Canada $0.522B 0.00
DURECT (DRRX) United States $0.521B 0.00
Siga Technologies (SIGA) United States $0.488B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.455B 11.00
BioSpecifics Technologies Corp (BSTC) United States $0.437B 17.05
Calithera Biosciences (CALA) United States $0.430B 0.00
Flexion Therapeutics (FLXN) United States $0.374B 0.00
MEI Pharma (MEIP) United States $0.371B 0.00
Ocular Therapeutix (OCUL) United States $0.365B 0.00
Organogenesis Holdings (ORGO) United States $0.354B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.348B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.334B 0.00
TherapeuticsMD (TXMD) United States $0.331B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.315B 0.00
Lannett Co Inc (LCI) United States $0.312B 6.84
Oasmia Pharmaceutical AB (OASMY) Sweden $0.293B 0.00
Concert Pharmaceuticals (CNCE) United States $0.291B 0.00
CASI Pharmaceuticals (CASI) United States $0.274B 0.00
Rafael Holdings (RFL) United States $0.266B 0.00
Redhill Biopharma (RDHL) Israel $0.253B 0.00
OptiNose (OPTN) United States $0.221B 0.00
VAXART, INC (VXRT) United States $0.206B 0.00
Xeris Pharmaceuticals (XERS) United States $0.203B 0.00
KalVista Pharmaceuticals (KALV) United States $0.202B 0.00
IMV INC (IMV) Canada $0.198B 0.00
PROFOUND MEDICL (PROF) Canada $0.196B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.186B 0.00
Jounce Therapeutics (JNCE) United States $0.185B 4.41
Taiwan Liposome (TLC) Taiwan $0.180B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.180B 0.00
Nature's Sunshine Products (NATR) United States $0.177B 23.36
Aquestive Therapeutics (AQST) United States $0.173B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.132B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.132B 0.00
PharmAthene (ALT) United States $0.131B 0.00
CV Sciences (CVSI) United States $0.118B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.118B 0.00
Recro Pharma (REPH) United States $0.113B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.113B 0.00
Sundial Growers (SNDL) Canada $0.098B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.089B 0.00
Heat Biologics (HTBX) United States $0.080B 0.00
SCYNEXIS (SCYX) United States $0.077B 0.00
Otonomy (OTIC) United States $0.076B 0.00
CTI BioPharma (CTIC) United States $0.076B 0.00
Hemispherx BioPharma (AIM) United States $0.070B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.067B 0.00
Biomerica (BMRA) United States $0.065B 0.00
Onconova Therapeutics (ONTX) United States $0.065B 0.00
Nivalis Therapeutics (ALPN) United States $0.063B 0.00
RENEURON GP (RNUGF) United Kingdom $0.060B 0.00
Iterum Therapeutics (ITRM) Ireland $0.059B 0.00
MediWound (MDWD) Israel $0.057B 0.00
Aclaris Therapeutics (ACRS) United States $0.055B 0.00
Infinity Pharmaceuticals (INFI) United States $0.055B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.054B 32.18
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.053B 0.00
GTx (ONCT) United States $0.049B 0.00
Lipocine (LPCN) United States $0.046B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.046B 99.09
IsoRay (ISR) United States $0.046B 0.00
Natural Alternatives (NAII) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Addex Therapeutics (ADXN) Switzerland $0.040B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.037B 0.00
Neos Therapeutics (NEOS) United States $0.037B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.037B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.037B 0.00
PolarityTE (PTE) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.035B 6.67
ElectroCore (ECOR) United States $0.035B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.035B 0.00
AgeX Therapeutics (AGE) United States $0.030B 0.00
Cardiome Pharma (CORV) Canada $0.028B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.026B 0.00
Jaguar Animal Health (JAGX) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
India Globalization Capital (IGC) United States $0.023B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
Novan (NOVN) United States $0.019B 0.00
ProPhase Labs (PRPH) United States $0.019B 0.00
Can-Fite Biopharma (CANF) Israel $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Shineco (TYHT) China $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Vical (BBI) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
HANCOCK JAFFE (HJLI) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00